---
title: "Gennex Laboratories Ltd (531739) — Share Price, Financials & Analysis"
symbol: "531739"
company: "Gennex Laboratories Ltd"
canonical: "https://tapetide.com/stocks/531739"
isin: "INE509C01026"
nse_symbol: "GENNEXLABORATORIESLTD"
bse_code: "531739"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 264.28
generated_at: "2026-09-13T19:41:18.017Z"
---

# Gennex Laboratories Ltd (531739)

Canonical page: https://tapetide.com/stocks/531739

## Company

- **NSE Symbol:** GENNEXLABORATORIESLTD
- **BSE Code:** 531739
- **ISIN:** INE509C01026
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** gennexlab.com

## About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:45.298338Z.

- **Market Cap:** ₹264.28 Cr
- **Classification:** Microcap
- **P/E (reported):** 13.2
- **EPS (TTM):** ₹0.76
- **EPS (reported):** ₹0.58
- **Book Value:** ₹9.16
- **Price to Book:** 1.22
- **Dividend Yield:** 0%
- **ROE:** 9.31%
- **ROCE:** 11.82%
- **Debt to Equity:** 0.36
- **Revenue (yearly):** ₹172.74 Cr
- **Net Income:** ₹21.19 Cr
- **EBITDA:** ₹21.84 Cr
- **52-Week High:** ₹17.25
- **52-Week Low:** ₹7.05
- **RSI (14):** 48.4

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Rising
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 52.14 | 9% |
| growth | 70.94 | 9% |
| momentum | 66.62 | 12% |
| ownership | 50 | 24% |
| quality | 39.12 | 22% |
| valuation | 50.4 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 34.4% CAGR over last 5 years

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 23.6%
- Tax rate seems low
- Company has a low return on equity of 9.82% over last 3 years.
- Debtor days have increased from 68.2 to 92.0 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 76.87% | -145.61% | -650% |
| ebitda margin growth | -7.25% | -34.04% | -49.58% | 11.76% |
| net income growth | 4.44% | 17.07% | 57% | 34% |
| revenue growth | -32.74% | 16.48% | 38% | 24% |
| roce | -4.52% | 14.53% | 57.18% | 11.57% |
| roe | 4.71% | 24.63% | 7.49% | -8.46% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 18.18 | 21.39 | 35.52 | 28.32 | 33.38 | 40.01 | 40.33 | 34.18 | 39.3 | 42.96 | 60.96 | 39.84 |
| Expenses | 12.41 | 16.59 | 29.26 | 24.1 | 25.92 | 32.86 | 38.31 | 29.11 | 31.74 | 34.39 | 55.07 | 35.46 |
| Operating Profit | 5.77 | 4.8 | 6.26 | 4.22 | 7.46 | 7.15 | 2.02 | 5.07 | 7.56 | 8.57 | 5.89 | 4.38 |
| OPM % | 31.74 | 22.44 | 17.62 | 14.9 | 22.35 | 17.87 | 5.01 | 14.83 | 19.24 | 19.95 | 9.66 | 10.99 |
| Other Income | 0 | 0 | 0 | 2.47 | 0 | 0 | 3.68 | 2.28 | 0 | -0.3 | 1.02 | 2.01 |
| Interest | 0.78 | 0.83 | 0.73 | 0.73 | 0.22 | 0.84 | 1.2 | 0.98 | 1.03 | 1.11 | 1.08 | 0.57 |
| Depreciation | 1.03 | 0.45 | 0.23 | 0.45 | 1.11 | 0.5 | 0.54 | 0.5 | 0.47 | 0.52 | 1.16 | 0.9 |
| Profit before tax | 3.96 | 3.52 | 5.3 | 5.51 | 6.13 | 5.81 | 3.96 | 5.87 | 6.06 | 6.64 | 4.67 | 4.92 |
| Tax % | 22.47 | 21.31 | 15.28 | 15.43 | 12.23 | 12.91 | 22.22 | 14.48 | 9.08 | 9.79 | 4.5 | 5.08 |
| Net Profit | 3.07 | 2.76 | 4.5 | 4.66 | 5.38 | 5.06 | 3.07 | 5.01 | 5.51 | 6 | 4.46 | 4.67 |
| EPS in Rs | 0.17 | 0.15 | 0.2 | 0.19 | 0.21 | 0.2 | 0.1 | 0.2 | 0.21 | 0.22 | 0.15 | 0.18 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 44 | 56 | 56 | 60 | 61 | 66 | 87 | 138 | 173 | 183 |
| Expenses | 42 | 52 | 52 | 53 | 56 | 61 | 70 | 121 | 150 | 157 |
| Operating Profit | 2 | 4 | 3 | 7 | 5 | 5 | 17 | 17 | 22 | 26 |
| OPM % | 5 | 7 | 6 | 11 | 9 | 7 | 20 | 12 | 13 | 14 |
| Other Income | 1 | 1 | 1 | 0 | 1 | 4 | 5 | 10 | 8 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| Profit before tax | 1 | 3 | 3 | 5 | 5 | 6 | 16 | 21 | 23 | 22 |
| Tax % | 42 | 26 | 27 | 20 | 23 | 23 | 20 | 15 | 10 | — |
| Net Profit | 1 | 2 | 2 | 4 | 4 | 5 | 13 | 18 | 21 | 21 |
| EPS in Rs | 0.04 | 0.12 | 0.1 | 0.21 | 0.21 | 0.28 | 0.58 | 0.8 | 0.76 | 0.76 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 18 | 23 | 23 | 24 |
| Reserves | 18 | 19 | 21 | 23 | 27 | 31 | 62 | 148 | 164 | 198 |
| Borrowings | 4 | 2 | 5 | 5 | 7 | 10 | 1 | 6 | 10 | 79 |
| Other Liabilities | 14 | 16 | 13 | 16 | 12 | 14 | 51 | 54 | 59 | 47 |
| Total Liabilities | 49 | 50 | 52 | 57 | 59 | 68 | 132 | 230 | 256 | 349 |
| Fixed Assets | 16 | 16 | 16 | 15 | 14 | 14 | 74 | 56 | 60 | 61 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 5 | 13 |
| Investments | 7 | 7 | 7 | 7 | 7 | 7 | 0 | 0 | 0 | 0 |
| Other Assets | 26 | 28 | 29 | 35 | 38 | 48 | 59 | 172 | 191 | 275 |
| Total Assets | 49 | 50 | 52 | 57 | 59 | 68 | 132 | 230 | 256 | 349 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 3 | 2 | -2 | -1 | 12 | 24 | -47 | -11 | -64 |
| Cash from Investing Activity | -1 | -1 | -1 | 0 | 0 | -2 | -38 | 19 | 1 | -5 |
| Cash from Financing Activity | 1 | -2 | 1 | 0 | 2 | -2 | 21 | 74 | 5 | 65 |
| Net Cash Flow | 0 | 0 | 2 | -2 | 0 | 8 | 6 | 46 | -5 | -3 |
| Free Cash Flow | -1 | 2 | 1 | -2 | -2 | 10 | -16 | -31 | -20 | -76 |
| CFO/OP | 13 | 190 | 55 | -52 | 1 | 242 | 505 | -274 | -45 | -274 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 90 | 87 | 68 | 41 | 55 | 67 | 52 | 75 | 37 | 92 |
| Inventory Days | 43 | 31 | 57 | 78 | 50 | 72 | 139 | 184 | 133 | 153 |
| Days Payable | 139 | 161 | 88 | 86 | 59 | 72 | 63 | 111 | 49 | 58 |
| Cash Conversion Cycle | -7 | -43 | 38 | 34 | 46 | 67 | 129 | 148 | 122 | 187 |
| Working Capital Days | 74 | 75 | 56 | 87 | 108 | 87 | 23 | 255 | 214 | 295 |
| ROCE % | — | 6 | 11 | 8 | 14 | 12 | 11 | 14 | 13 | 11 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 23.6% | 23.6% | 18.42% | 18.42% | 18.42% | 18.42% | 18.42% | 19.83% | 23.62% | 23.62% | 23.63% | 23.63% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 58.05% | 60.22% | 60.42% | 61.74% | 59% | 60.53% | 62.19% | 61.9% | 59.34% | 56.47% | 55.79% | 56.49% |
| Others | 18.34% | 16.17% | 21.16% | 19.85% | 22.59% | 21.05% | 19.39% | 18.28% | 17.04% | 19.91% | 20.58% | 19.88% |
| No. of Shareholders | 50988 | 69723 | 83996 | 87820 | 90236 | 92506 | 92326 | 91183 | 90320 | 86306 | 84133 | 82886 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 8 / 3 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 11.77 | Sell |
| EMA (10) | 11.59 | Sell |
| SMA (20) | 12 | Sell |
| EMA (20) | 11.49 | Sell |
| SMA (50) | 10.36 | Buy |
| EMA (50) | 10.91 | Buy |
| SMA (100) | 10.47 | Buy |
| EMA (100) | 10.75 | Buy |
| SMA (200) | 11.17 | Sell |
| EMA (200) | 11.11 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.28 | Neutral |
| MACD (12,26,9) | 0.28 | Sell |
| Stochastic (14,3,3) | 7.98 | Buy |
| ADX (14) | 38.12 | Buy |
| Williams %R (14) | -85.99 | Buy |
| ATR (14) | 0.71 | High Volatility |
| ROC (12) | -8.91 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 34.4 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f507371-6205-4c34-b478-3d393b394e53.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d6736c0-17b7-45ee-9637-b0821ac066d1.pdf) |
| 2026-09-08 | [Approval Of Additional Products From Drugs Control Administration Government Of Andhra Pradesh For Our Subsidiary Company Deccan Remedies Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edbc2d3b-5722-4cbe-91e9-a9af3172ff5c.pdf) |
| 2026-09-04 | [Board Meeting Outcome for Meeting Held On September 04 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1131b1b0-a282-4f03-ae60-1d60e9125e3a.pdf) |
| 2026-09-04 | [Intimation Of Book Closure For The Purpose Of 41St AGM Of Gennex Laboratories Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6efc0f9b-7922-4e64-bf10-b8cb11e4f97f.pdf) |
| 2026-08-27 | [Board Meeting Intimation for For Fixing Date Time And Venue Of 41St AGM Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7af091c0-9541-441e-9c92-08089c80f724.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc52d45f-5a83-4f8c-906e-16427c693ef7.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9648e0c6-cea5-48a1-8e29-8d9fa2ee8ac3.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb4dea65-d42f-4abf-bf26-4d3946624497.pdf) |
| 2026-07-29 | [Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfb74261-d925-4aeb-96a2-87800b097750.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Un-Audited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d0ac1f2-ecd6-47c6-a7e7-835facda1e5c.pdf) |
| 2026-05-30 | [Financial Result For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de45ae65-e0b6-4f0a-ac9c-e5880dd277f9.pdf) |
| 2026-02-14 | [Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcbf66c9-c4f4-474a-8106-f9aa19e7b5c7.pdf) |
| 2025-11-14 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67e0e56d-4a49-431d-b4f5-b5155522be32.pdf) |
| 2025-08-14 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbbb9833-75b8-46fe-8748-cc560064db3c.pdf) |
| 2025-05-30 | [Audited Financial Results For The Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cef147f7-be21-4076-a41c-7ee1a56afc37.pdf) |
| 2025-02-14 | [Unaudited Financial Results For Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33fae676-8417-4f70-9b99-eeb1dd609512.pdf) |
| 2024-11-14 | [Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72b4beb0-c80f-4022-b56d-66bccf7de4ce.pdf) |
| 2024-08-14 | [Financial Results For Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66f4bd79-fb93-4ad9-bd92-a4c402a2df3f.pdf) |
| 2024-05-30 | [Financial Results For The Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aa3b4f8-c477-4687-821f-c21615848c85.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Intimations done by the Company on 28th Jan 2026, 4th Feb 2026 and 5th Feb 2026 with respect to the Result Conference Call hosted by … | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 9 Feb - Intimations done by the Company on 28th Jan 2026, 4th Feb 2026 and 5th Feb 2026 with respect to the Result Conference Call hosted by …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dd5a75f0-f1e8-4d85-a4bd-d4bbad0cb171.pdf) |
| 8 Apr - Board meets April 16, 2026 to consider EGM for regularizing Ms. Khushbu Kachhawa as independent woman director. | [Board Meeting Intimation for Meeting To Be Held On Thursday, April 16, 2026 8 Apr - Board meets April 16, 2026 to consider EGM for regularizing Ms. Khushbu Kachhawa as independent woman director.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a725a0d0-d069-432d-9fda-f9fbeb208371.pdf) |
| 5 Feb - The management of the Company shall be participating in the Institutional Investors group meetings to be held on 10th Feb 2026 and 26th Feb 2026. … | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 Feb - The management of the Company shall be participating in the Institutional Investors group meetings to be held on 10th Feb 2026 and 26th Feb 2026. …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c0de1589-a96e-4096-a4ff-31c76bd0a3df.pdf) |
| 5 Feb - Audio of Feb 5, 2026 results conference call for quarter ended Dec 31, 2025 uploaded. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 5 Feb - Audio of Feb 5, 2026 results conference call for quarter ended Dec 31, 2025 uploaded.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f53c3dd5-f352-4b9c-b702-caf37298baa0.pdf) |
| 4 Feb - Q3 results; re-appointment of MD; plan UAE 1.65 MTPA grinding unit, USD39m capex, USD29.25m guarantee. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 4 Feb - Q3 results; re-appointment of MD; plan UAE 1.65 MTPA grinding unit, USD39m capex, USD29.25m guarantee.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e9aeb1dc-1fd1-4868-bdce-b62232241831.pdf) |
| 21 Apr - Newspaper Publication of EGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Local-Telugu) on April 21, 2026 for the Extraordinary General … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Apr - Newspaper Publication of EGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Local-Telugu) on April 21, 2026 for the Extraordinary General …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e91c1494-bdab-43d4-811f-f91e8fb973ec.pdf) |
| 20 Apr - EGM on May 12, 2026 to appoint Ms. Khushbu Kachhawa as Independent Woman Director. | [Notice Convening Extraordinary General Meeting (EGM) To Be Held On Tuesday, May 12, 2026 Through VC And OAVM 20 Apr - EGM on May 12, 2026 to appoint Ms. Khushbu Kachhawa as Independent Woman Director.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2389e93-4538-4c02-9a4a-1da9056fe84c.pdf) |
| 2 Mar - Declared preferred bidder (02-Mar-2026) for Sikilangso Limestone Blocks A&B, 200 hectares each, Umrangso, Assam. | [Declared As Preferred Bidders In E-Auction. 2 Mar - Declared preferred bidder (02-Mar-2026) for Sikilangso Limestone Blocks A&B, 200 hectares each, Umrangso, Assam.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f90910e-46f8-4337-b336-e2c0a6873455.pdf) |
| 17 Feb - Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31, 2025 announced by the Board in its … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Feb - Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31, 2025 announced by the Board in its …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/694cc5bd-eb3a-459c-9c7a-2fe43102e522.pdf) |
| 17 Apr - Board approved EGM on May 12, 2026 to regularize Ms. Khushbu Kachhawa as independent woman director. | [Board Meeting Outcome for Revised Outcome 17 Apr - Board approved EGM on May 12, 2026 to regularize Ms. Khushbu Kachhawa as independent woman director.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/537a4d95-f944-4d12-9bb1-b75957360b92.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a435c58a-3391-428f-af29-9e070ae9d3e2.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/45cf2e4a-da6a-448c-8a0d-0c1e8f0cf16e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f2a69a7-0c57-4b01-83e4-cb5754862fee.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4144713b-6634-4927-8b5b-b6ede11bd488.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93c741f1-dc3f-4e8f-837a-218fc3da789e.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/76994531739.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/72156531739.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/66562531739_08_09_20.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/5317390319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/5317390318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/5317390317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/531739/5317390316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:41:18.017Z.